COMPOSITION FOR CONTROLLED RELEASE OF DRUGS COMPRISING AMNIOTIC MEMBRANE-ALGINATE GEL COMPLEX, AND PREPARING METHOD THEREOF

The present invention relates to a composition for controlled release of drugs, which comprises an amniotic membrane (AM) carrying pharmaceutically acceptable salt; and alginate gel attached to the AM as a barrier, wherein the alginate gel contains alginate and calcium, and the calcium is cross-link...

Full description

Saved in:
Bibliographic Details
Main Authors RO, JI EUN, NA, YEON JOO, KIM, JAE CHAN, KIM, HYEONG MIN, LEE, JAE HWI
Format Patent
LanguageEnglish
Korean
Published 28.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a composition for controlled release of drugs, which comprises an amniotic membrane (AM) carrying pharmaceutically acceptable salt; and alginate gel attached to the AM as a barrier, wherein the alginate gel contains alginate and calcium, and the calcium is cross-linked to the alginate. In the composition for controlled release of drugs according to the present invention, the alginate and Ca^2+ are cross-linked so as to form gel of a strong net structure, and this alginate gel is attached to the AM carrying the drugs as the role of a barrier. Therefore, the composition can control release of the drugs carried on the AM by concentration of the calcium and/or concentration of the alginate, whereby can be usefully applied to therapeutic agents for treatment of eye disease.
Bibliography:Application Number: KR20130041873